We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$2.11B
AUM Growth
+$753M
Cap. Flow
+$625M
Cap. Flow %
29.67%
Top 10 Hldgs %
29.41%
Holding
529
New
28
Increased
187
Reduced
232
Closed
16

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.8M
2
AMZN icon
Amazon
AMZN
+$43.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.3M
4
UNH icon
UnitedHealth
UNH
+$33.1M
5
V icon
Visa
V
+$32.4M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$2.56M
2
ORCL icon
Oracle
ORCL
+$2.15M
3
ALL icon
Allstate
ALL
+$1.59M
4
GILD icon
Gilead Sciences
GILD
+$1.57M
5
EQR icon
Equity Residential
EQR
+$1.39M

Sector Composition

Rank Sector Weight
1 Technology 25.67%
2 Healthcare 17.01%
3 Financials 13.61%
4 Communication Services 9.89%
5 Consumer Discretionary 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
501
Halliburton
HAL
$28.2B
$208K 0.01%
8,982
-1,770
-16% -$39.3K
TRMB icon
502
Trimble
TRMB
$13.5B
$208K 0.01%
+2,542
New +$202K
TDY icon
503
Teledyne Technologies
TDY
$31.6B
$207K 0.01%
494
-130
-21% -$55.2K
WORK
504
DELISTED
Slack Technologies, Inc.
WORK
$206K 0.01%
+4,660
New +$199K
CVNA icon
505
Carvana
CVNA
$79.2B
$205K 0.01%
+3,400
New +$185K
PAYC icon
506
Paycom
PAYC
$9.57B
$205K 0.01%
+564
New +$200K
NDAQ icon
507
Nasdaq
NDAQ
$53.1B
$204K 0.01%
+3,480
New +$192K
NVCR icon
508
NovoCure
NVCR
$2.06B
$204K 0.01%
+920
New +$179K
NVR icon
509
NVR
NVR
$17.1B
$204K 0.01%
+41
New +$199K
ALNY icon
510
Alnylam Pharmaceuticals
ALNY
$29.6B
$200K 0.01%
+1,180
New +$173K
VTRS icon
511
Viatris
VTRS
$18.7B
$179K 0.01%
12,504
-7,807
-38% -$113K
PCG icon
512
PG&E
PCG
$38.1B
$154K 0.01%
15,120
SIRI icon
513
SiriusXM
SIRI
$9.61B
$71K ﹤0.01%
1,080
-4,355
-80% -$273K
COR icon
514
Cencora
COR
$63.7B
-2,634
Closed -$311K
CTRA
515
DELISTED
Coterra Energy
CTRA
-14,280
Closed -$268K
EG icon
516
Everest Group
EG
$14B
-5,485
Closed -$1.36M
HSIC icon
517
Henry Schein
HSIC
$9.94B
-4,213
Closed -$292K
IONS icon
518
Ionis Pharmaceuticals
IONS
$9.21B
-7,730
Closed -$348K
LVS icon
519
Las Vegas Sands
LVS
$29.6B
-3,791
Closed -$230K
NBIX icon
520
Neurocrine Biosciences
NBIX
$16.5B
-4,900
Closed -$477K
NRG icon
521
NRG Energy
NRG
$25.2B
-6,729
Closed -$254K
OC icon
522
Owens Corning
OC
$12.6B
-2,405
Closed -$221K
RNR icon
523
RenaissanceRe
RNR
$13.2B
-7,614
Closed -$1.22M
TXT icon
524
Textron
TXT
$15.2B
-3,745
Closed -$210K
UHS icon
525
Universal Health Services
UHS
$9.94B
-1,580
Closed -$211K

Similar funds

Meiji Yasuda Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Meiji Yasuda Asset Management held 529 positions worth $2.11B, up 56% from $1.35B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Meiji Yasuda Asset Management deployed $625M of net new capital in Q2 2021, opening 28 new positions and adding to 187 existing holdings. Its largest new stake was Graco: 200,100 shares worth $15.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $2.56M trimmed.

  • Meiji Yasuda Asset Management's largest Q2 2021 buy was Graco: 200,100 shares worth $15.1M.
  • Meiji Yasuda Asset Management added most to Microsoft in Q2 2021, an estimated $50.8M increase.
  • Meiji Yasuda Asset Management's biggest Q2 2021 reduction was RTX Corp, cutting an estimated $2.56M.
  • Meiji Yasuda Asset Management fully exited Everest Group in Q2 2021, selling an estimated $1.36M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 29% of its $2.11B portfolio in Q2 2021.
  • Meiji Yasuda Asset Management opened 28 new positions and closed 16 in Q2 2021.
  • Meiji Yasuda Asset Management's portfolio value rose 56% quarter-over-quarter to $2.11B.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.